C. elegans insulin-like peptides.
Autor: | Zhu R; Department of Biology, Queen's University, Kingston ON Canada., Chin-Sang ID; Department of Biology, Queen's University, Kingston ON Canada. Electronic address: chinsang@queensu.ca. |
---|---|
Jazyk: | angličtina |
Zdroj: | Molecular and cellular endocrinology [Mol Cell Endocrinol] 2024 May 01; Vol. 585, pp. 112173. Date of Electronic Publication: 2024 Feb 10. |
DOI: | 10.1016/j.mce.2024.112173 |
Abstrakt: | Insulin-like peptides are a group of hormones crucial for regulating metabolism, growth, and development in animals. Invertebrates, such as C. elegans, have been instrumental in understanding the molecular mechanisms of insulin-like peptides. Here, we review the 40 insulin-like peptide genes encoded in the C. elegans genome. Despite the large number, there is only one C. elegans insulin-like peptide receptor, called DAF-2. The insulin and insulin-like growth factor signaling (IIS) pathway is evolutionarily conserved from worms to humans. Thus C. elegans provides an excellent model to understand how these insulin-like peptides function. C. elegans is unique in that it possesses insulin-like peptides that have antagonistic properties, unlike all human insulin-like peptides, which are agonists. This review provides an overview of the current literature on C. elegans insulin-like peptide structures, processing, tissue localization, and regulation. We will also provide examples of insulin-like peptide signaling in C. elegans during growth, development, germline development, learning/memory, and longevity. Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |